Burning Rock Dx

Biotechnology ResearchUnited States501-1000 Employees

Burning Rock Biotech Limited (NASDAQ: BNR )

Burning Rock Biotech is a global diagnostics company specializing in next-generation sequencing (NGS) technology for precision oncology.

Our Mission
Guard Life via Science

Our Vision
To Become a New Pillar in the International Healthcare Industry

What We Offer
We provide solutions throughout the precision oncology development cycle, including:
NGS-Based Assays: Comprehensive portfolio for tissue and blood samples
In-House Database: Facilitating clinical trial studies and research
Pharmaceutical Partner Services:
 Genomic data solutions
 Clinical trial solutions
 Precision patient recruitment
 Companion diagnostics (CDx) development and commercialization

Global Operations
With CLIA/CAP laboratories in China and the United States, we support global clinical trials. Our achievements include:
2 NMPA-Approved IVD Kits
4 Assays with CE Marking
Breakthrough Device Designation (BDD) from both the US FDA and China NMPA for multi-cancer detection blood tests

Leveraging advanced NGS technology and extensive pharmaceutical partnerships, Burning Rock is dedicated to advancing precision oncology worldwide.

Sign up for free to view info

Email Format Employee directory